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Abstract
Introduction: Patients with chronic kidney disease often experience emotional/
mental challenges and benefit from peer support, as it provides insight/information
from others with the same condition. Previous studies show it is effective in
improving health outcomes and aids in treatment decisions.
Literature Review: There is low peer support uptake among patients with chronic
kidney disease in the United Kingdom and staff do not utilise peer support services
fully. Few studies within the United Kingdom have focused on peer support bar-
riers/facilitators, so this narrative review aimed to understand them from staff and
patient perspectives.
Materials and Methods: A comprehensive search strategy and inclusion/exclusion
criteria were applied with a two‐step process of article selection employed using
two reviewers. Thematic analysis was applied.
Results: Five articles were included and six themes emerged. Low referrals and
difficulty matching were staff barriers; concern regarding the relationship dynamic
and the format/delivery were patient barriers. Promotion of the service aided the
uptake from staff, while patients valued inclusivity.
Discussion: Increased promotion of peer support benefits through training/awareness
may improve staff referrals and there should be greater exposure nationally.
A flexible format is essential to ensure ample opportunity for access.
Conclusion: This review highlights the current literature on peer support barriers/
facilitators. Further study is needed to evidence which approaches best overcome
staff‐ and patient‐barriers.
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INTRODUCTION
The experience of being diagnosed with chronic kidney disease (CKD)
can often be overwhelming as it requires a number of behavioural
changes and can be accompanied by both emotional and mental chal-
lenges (Morton, Tong, Howard, Snelling, & Webster, 2010). The com-
plexity of the condition and the resulting impact on the individual and
family may affect the quality of life and independence (Burnier, Pruijm,
Wuerzner, & Santschi, 2015). To provide opportunities for people with
CKD to overcome such adversity, in the UK, peer support (PS)
programmes are policy‐recommended (Department of Health, 2013), as
they can help people with the same chronic condition to gain insight from
one another through the sharing of experiences and information (Perry
et al., 2005). Additionally, since the National Health Service (NHS) in the
United Kingdom faces repeated budgetary and staff shortages, PS is a
suitable and low‐cost supplement to standard clinical services on kidney
units (Wood, 2014).
PS programmes have been shown to be effective in helping
people manage long‐term conditions, such as mental health dis-
orders, cancer and HIV/AIDS. The type and duration of PS can be
structured differently depending on the environment and goals of
the service but can resemble teaching, mentoring, buddying, one‐to‐
one support or group sessions (Hughes, Wood, & Smith, 2009). PS is
classified as informal, conducted by a fellow patient, or formal, im-
plemented by a fully trained peer supporter. More specifically,
Ghahramani (2015, p. 241) has broken down PS into seven cate-
gories: “professional‐led group visits; peer‐led self‐management
training; peer coaches; community health workers; support groups;
telephone‐based peer support; and web‐ and email‐based programs.”
A person's response to receiving PS is often positive, as re-
cipients can learn coping strategies and ways of managing their
condition (Winterbottom, Bekker, Conner, & Mooney, 2012). Sup-
porters who have lived experience of CKD are in an advantageous
position to address questions and concerns of newly diagnosed pa-
tients in comparison with general healthcare professionals as they
have a stronger sense of awareness and relatability (Heisler, 2006).
Previous studies on peer mentoring between individuals with CKD
have evidenced benefits such as providing a source of information
for people and aiding PS recipients in feeling heard and understood
given the supporters' authentic experience of the condition (Wood,
2014). It has also shown to improve self‐efficacy and emotional well‐
being (Hughes et al., 2009), aid in treatment decisions (Hughes et al.,
2009; Winterbottom et al., 2012) and relieve certain fears regarding
specific procedures and therapies (Winterbottom et al., 2012). Ad-
ditionally, trust can be developed among recipients of PS and has
shown to decrease health disparities, especially among dis-
advantaged groups (Perry et al., 2005). Despite claims in the past
that peer supporters might provide erroneous information, this can
be combatted by ensuring peer supporters are trained on a regular
basis and advised against delivering any medical‐related advice
(Wood, 2014).
Although PS is generally well‐received by PS recipients, there is low
uptake for formal PS among patients with CKD in the United Kingdom
(Hughes et al., 2009; Taylor, Gutteridge, & Willis, 2016; Wood, 2014).
The problem is not unique to PS in kidney care. Accordingly, National
Voices (2015) in the UK put out a nationwide call to utilise both vo-
lunteer and community groups to produce more opportunities for PS.
Aims of the review
To increase overall participation in PS programmes within kidney units
across the United Kingdom, it is imperative to first understand the
patient and staff perspectives, which either deter or facilitate access
to PS opportunities (Taylor et al., 2016). Once identified, these par-
ticular aspects can then be addressed, with alternative solutions
proposed, if appropriate. A number of studies have focused on barriers
and/or facilitators to PS uptake in geographic areas like the United
States (Liaghat, 2017) and Canada (Nicholas et al., 2009), but fewer
have been cited within the United Kingdom. A narrative review format
was therefore chosen so a UK‐specific perspective of current litera-
ture could be better understood, with emerging themes presented.
Review question
This narrative review was conducted to synthesise what is presently
understood, surrounding both healthcare staff‐ and patient‐related
barriers and facilitators to PS for people with CKD in the United
Kingdom, to influence future practice and recommendations within
this field. The review question “What are the barriers and facilitators
to accessing peer support in kidney care?” was used throughout to
guide the search process and analysis of findings.
METHODS
Search strategy
A robust and comprehensive search strategy was employed to
identify articles, which addressed or related to barriers and/or fa-
cilitators to PS among staff or patients with CKD. A list of search
terms was created by reviewing literature surrounding the topic,
together with the use of an independent synonym‐generation ex-
ercise. A manual search of the reference lists of articles found was
also conducted to ensure maximum papers, which answered the
research question were included. Robust inclusion/exclusion criteria
(Table 1) were developed and applied to ensure that eligibility was
consistent. The PICO model was employed throughout the search so
the topic could be clearly defined: Problem—CKD or transplant;
Intervention—PS; Comparison—barriers/facilitators; Outcome—
uptake. No specific publishing timeframe was selected to maximise
the number of search results and potential articles to be included.
Ethical oversight was not required by any ethics committee for this
narrative review, given it only included previously published articles.
The PRISMA checklist (Moher, Liberati, Tetzlaff, Altman, & The
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PRISMA Group, 2009) was used as a reporting guideline to ensure
that the narrative review consisted of all necessary components to
be considered a sufficient scope of the literature.
Study selection
Selection of the articles was completed through a two‐step process:
Studies in which the title or abstract related to any barriers and/or
facilitators to PS among staff or patients with CKD were compiled;
subsequently, these studies were then reviewed more in‐depth by
two reviewers against the inclusion/exclusion criteria, yielding a
finalised list of studies to include in the narrative review. Reasons for
exclusion included but were not limited to articles on non‐kidney‐
related PS programmes, studies only examining kidney health
knowledge or prevalence, and the cost–benefit analysis of PS. Upon
collating the findings of the included articles, thematic analysis was
applied, which provided insight into general trends throughout the
narrative review.
Thematic analysis
Thematic analysis (Nowell, Norris, White, & Moules, 2017) was em-
ployed to identify the most common patterns within the literature. A
single reviewer, familiar with the literature, first went through each
article and assigned codes accordingly, generating a list. From this
list, similar codes were grouped together into categories to create
the first set of themes, which were then sent to the other authors to
review. Following collaboration and mutual consent between the
authors, a finalised list of themes was produced.
RESULTS
Search results
The initial electronic search produced 402 articles in English, re-
duced to 28 following geographic specifications to the United
Kingdom. All 28 titles and abstracts were reviewed against the in-
clusion/exclusion criteria, and 11 then moved on to the full‐text re-
view stage. Following this, six articles were included as five failed to
address the research question. Of the six included, three were
deemed “duplicates,” as they discussed the same results as other
articles included in the narrative review. Of the manual search of
various reference lists, 23 articles were selected to review their
abstracts against the inclusion/exclusion criteria. From a more in‐
depth cross‐reference, it was found that a number of them were
already included in the narrative review, and only an additional two
articles were included in the final number. Collectively, the electronic
and manual searches yielded five articles to be included in the overall
narrative review (Figure 1 and Table 2).
All five articles included mentioned at least one or more of both
barriers and facilitators to PS uptake. Four articles assessed barriers and
TABLE 1 Review search strategy
Keywords Databases Dates Inclusion criteria
P—Kidney OR Renal OR Dialysis OR Transplant OR Renal
replacement therapy OR Chronic kidney disease OR
CKD OR End‐stage kidney disease OR End‐stage
renal failure
JSTOR 15
October
2019
Studies performed in the United Kingdom
I—Peer support OR Peer program* OR Peer service OR
Peer group OR Peer advice OR Peer guidance OR
Community support OR Community program* OR
Community service OR Community group OR
Community advice OR Community guidance
EBSCO 18
October
2019
Studies focusing solely or partly on people with kidney
disease (CKD or dialysis or transplant)
C—Barriers OR Limit OR Challenge OR Obstacle OR
Restriction OR Constraint AND Facilitator OR
Enabler OR Promoter
Project Muse 20
October
2019
Studies examining participants over 18 years old
O—Uptake OR Engage OR Attend OR Experience OR
Attitude OR View OR Perception OR Opinion OR
Belief OR Behavio*
Medline 21
October
2019
Studies examining peer support programmes for
kidney patients individually or in combination with
another chronic illness
CINAHL 22
October
2019
Studies examining one or all of the experiences,
barriers and/or facilitators of peer support uptake
among kidney patients or staff working on renal units
Psychinfo Studies reporting primary research, systematic or
literature reviews
Google
Scholar
Studies published in English
Abbreviation: CKD, chronic kidney disease.
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F IGURE 1 Search selection results
TABLE 2 Articles selected
Author Title Methodology Perspective Findings
1. Hughes
et al. (2009)
Exploring kidney patients' experiences of
receiving individual peer support
Qualitative Patient and staff
perspective
Four main themes emerged:
1. Interaction with the peer supporter
2. Benefits of peer support
3. Contrasts between peer support
and other sources of information
4. The peer supporter as a role model
2. Jeffries
et al. (2015)
Participation in voluntary and community
organisations in the United Kingdom and
the influences on the self‐management of
long‐term conditions
Qualitative Patient
perspective
1. Reasons for participation (pursuing
a hobby to connect to others,
participation as a catalyst for
change)
2. Barriers to participation (temporal
and spatial barriers, group
dynamics)
3. Maintaining membership
(embedded participation and
belonging, involvement and support)
3. McCarthy and
Mastin
(2016)
Development and delivery of a diverse peer
support programme for renal service users,
their family and carers: an action research
collaboration
Qualitative Patient and staff
perspective
1. Evaluation of peer support training
2. Dissemination
3. Claims, concerns and issues
4. Challenges/barriers
5. Current situation
4. Taylor
et al. (2016)
Peer support for CKD patients and carers:
overcoming barriers and facilitating access
Qualitative Patient
perspective
1. Perceived benefits of peer support
over other sources of support
2. The peer support occasion
3. Permission to engage
4. An attractive peer relationship
5. Building rapport
6. Choice and control
5. Wood (2014) Patient‐to‐patient peer support in renal
care: examining the role and attitudes of
renal clinicians
Quantitative and
qualitative
Staff perspective 1. Perceived outcomes of peer support
2. Perceptions of the service
3. Suggestions for service
improvements
Abbreviation: CKD, chronic kidney disease.
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facilitators from a patient perspective (Hughes et al., 2009; Jeffries et al.,
2015; McCarthy & Mastin, 2016; Taylor et al., 2016) and three assessed
barriers and facilitators from healthcare staff perspectives (Hughes et al.,
2009; McCarthy & Mastin, 2016; Wood, 2014). Only two (Hughes et al.,
2009; McCarthy & Mastin, 2016) provided insight into both patient and
provider perspectives together; however, Wood (2014) also commented
on staff's perceived outcomes for PS recipients. Themes surrounding
barriers to PS were more common than facilitators among the articles.
Following analysis, six main themes became apparent: patient reasons for
PS participation; staff barriers to utilising PS; patient barriers to engaging
in PS; staff drivers to utilising PS; patient drivers to engaging in PS;
positive outcomes of engaging in PS.
Of the number of patient reasons cited for deciding to take part in
a PS programme, the most common were informational and emotional
support, each listed in three of the five articles, respectively. For in-
formational support, patients chose to participate because they wanted
answers to their questions and were seeking information (Hughes et al.,
2009; Taylor et al., 2016; Wood, 2014). For emotional support, many
patients wanted someone to talk to about what they were going
through (Hughes et al., 2009; Jeffries et al., 2015; Wood, 2014). A less
significant reason, found in only two articles, was the desire to receive
help with treatment decisions (Hughes et al., 2009; Taylor et al., 2016).
Staff barriers to utilising PS
Low staff referrals were found as the most prominent barrier to
people with CKD accessing PS, cited in each of three articles, which
assessed staff perspectives (Hughes et al., 2009; McCarthy & Mastin,
2016; Wood, 2014). The most common reasons for low referral rates
were that they are considered a time‐consuming and/or difficult
process (Hughes et al., 2009; McCarthy & Mastin, 2016; Wood,
2014) and that clinicians only refer a small number of restricted
times in the care journey (Hughes et al., 2009; McCarthy & Mastin,
2016; Wood, 2014). Less prominent reasons for low referrals in-
cluded clinicians being unaware of the referral process (McCarthy &
Mastin, 2016; Wood, 2014), concerns the peer supporter could be-
come overburdened (Hughes et al., 2009; Wood, 2014) and the false
assumption that nurses, not doctors, are the ones meant to refer
(Hughes et al., 2009; McCarthy & Mastin, 2016). A second common
staff‐related barrier was difficulty in matching peer supporters to PS
recipients (Hughes et al., 2009; McCarthy & Mastin, 2016). While
there lacked consensus among the articles reviewed as to a specific
reason for this, suggestions included limited availability of a diverse
pool of peer supporters (Hughes et al., 2009) and patients having
undisclosed preferences for what they are looking for in a peer
supporter (McCarthy & Mastin, 2016).
Patient barriers to engaging in PS
Concern regarding the PS relationship dynamic was found to be the
largest deterrent for individuals choosing to engage in PS, found in
three articles, which discussed patient‐specific barriers (Hughes
et al., 2009; Jeffries et al., 2015; Taylor et al., 2016). Apprehensions
were lack of rapport with their peer supporter (Jeffries et al., 2015;
Taylor et al., 2016), the peer supporter being negative or frightening
(Hughes et al., 2009) and a desire to have a more reciprocal re-
lationship (Taylor et al., 2016). A second barrier, found in two arti-
cles, was concern surrounding the format and delivery of PS (Jeffries
et al., 2015; Taylor et al., 2016). For instance, lack of time due to
other commitments and responsibilities (Jeffries et al., 2015),
meeting location challenges (Jeffries et al., 2015) and a desire to
choose the timing and delivery of the support (Taylor et al., 2016)
were some specific examples of format and delivery barriers.
Staff drivers to utilising PS
Promoting PS among clinicians was found to be the only significant
facilitator enabling staff to utilise PS, cited in each of the three articles
on staff perspectives (Hughes et al., 2009; McCarthy & Mastin, 2016;
Wood, 2014). A successful method of promotion with clinicians was
having link nurses raise awareness about PS and its associated
benefits through announcements at meetings, emails and informal
conversations with their colleagues (Hughes et al., 2009; McCarthy &
Mastin, 2016; Wood, 2014). Another suggestion was to have leaflets
in consulting rooms in outpatient clinics as a mode of positive re-
inforcement for clinicians to remember to refer (Hughes et al., 2009).
Patient drivers to engaging in PS
An inclusive service was the leading factor for people choosing to
engage in PS, referenced in three articles assessing patient drivers
(Hughes et al., 2009; Jeffries et al., 2015; Taylor et al., 2016).
Although there lacked a common definition of what an inclusive
service entails, suggestions included allowing self‐referrals (Hughes
et al., 2009), having recipients play a key role in choosing their peer
supporter (Taylor et al., 2016) and ensuring the support is accom-
modating and catered to the patient (Jeffries et al., 2015).
Positive outcomes of engaging in PS
The most frequent positive outcome of engaging in PS, listed in all
five articles, was the interaction providing an opportunity for the
patient to receive emotional support (Hughes et al., 2009; Jeffries
et al., 2015; McCarthy & Mastin, 2016; Taylor et al., 2016; Wood,
2014). Secondly, PS was also established as a helpful approach for
recipients to gain information and answers to their questions
(Hughes et al., 2009; Jeffries et al., 2015; Taylor et al., 2016; Wood,
2014). Lastly, PS was cited as a positive experience because it
provides reassurance for people and helps them increase their
confidence in decision‐making (Hughes et al., 2009; Jeffries et al.,
2015; Taylor et al., 2016).
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DISCUSSION
The narrative review's findings have identified staff‐ and patient‐
related barriers and facilitators to PS uptake among people with
CKD in the United Kingdom and poses useful suggestions for how to
address them accordingly. This discussion aims to analyse such
findings, identify areas for improvement and suggest recommenda-
tions for practice.
Overcoming healthcare staff barriers
Healthcare staffs have a significant impact on a patient's level of
engagement, and a programme's success is directly correlated
to the amount of support and referrals made by clinicians
(McCarthy & Mastin, 2016). PS referral processes have been found
to be considered mysterious, time‐consuming and/or difficult and
some clinicians only consider referring at specific times in the care
journey. Moreover, staffs have stated it can be challenging to
match recipients with peer supporters based on similarities if
there is a limited peer supporter pool and if recipients have
preferential traits they are looking for. Although matching
requires a time commitment and the requisite knowledge of who is
available, pairing recipients with peer supporters as closely as
possible makes the service immensely more successful and
effective (Hughes et al., 2009).
By promoting PS among clinicians, specifically through in-
creased training and awareness on service practicalities, govern-
ance, and PS benefits, staff may, in turn, increase their referrals.
Greater exposure nationally and internationally for PS may also
improve clinician confidence in the service and aid as a reminder
to refer throughout the entire care journey. Since some clinicians
may unintentionally recommend PS more to some patient groups
over others, the effort is therefore needed to avoid these as-
sumptions to promote equality of access (Krizek, Roberts, Ragan,
Ferrara, & Lord, 1999). For instance, PS opportunities offered
through national organisations could help to increase knowledge
and understanding of the benefits (McCarthy & Mastin, 2016).
Notably, the promotion of PS among clinicians was the main staff
facilitator found in the narrative review and can have a significant
impact (Wood, 2015). By increasing awareness, more staff will also
be aware of who could be recruited as a peer supporter, which
would aid in increasing diversity and expanding the number of
peer supporters. Crucially, ensuring clinicians understand how
their engagement affects the overall success of PS could enhance
their motivation to refer as well as support with the recruitment
and matching process. For instance, past potential recipients have
stated their desire for clinicians to affirm that PS is appropriate for
them and that they may not engage unless they receive such
confirmation (Taylor et al., 2016). Ultimately, if staff are confident
and motivated to frequently promote PS to patients, the oppor-
tunities for people to engage will be maximised (Wood, 2014).
Overcoming patient barriers
Having peer supporters who are welcoming and comfortable to en-
gage with is seen as imperative among a number of recipients. The
promotion and explanation of PS to potential recipients, which em-
phasises that supporters are trained and expected to be positive and
understanding role models may alleviate potential fears (Hughes
et al., 2009). As found by Taylor et al. (2016), the term “peer support”
can be perceived negatively or entirely misunderstood, so framing it
in a way, which highlights its informality and clarifying the true in-
tention and potential positive outcomes may attenuate concerns. An
additional opportunity for PS recipients to provide feedback to
clinicians about peer supporters could also reassure recipients that
they will have support even if there are issues with the relationship
dynamic. Ensuring supporters are taught during training sessions
about the significance of providing a safe and empathetic environ-
ment could also have a sizeable impact on tackling this barrier.
Ultimately, the flexibility of the programme's format and delivery is
essential to ensure ample opportunity for access (Taylor et al., 2016).
This highlights what was found as a prominent facilitator in the nar-
rative review, providing an inclusive PS service. The timing of PS can
influence whether a person will participate or not, given that individuals
desire PS at different times throughout their disease trajectory
(Embuldeniya et al., 2013; Smith et al., 2011) and reach acceptance of
external support at varying times (Taylor et al., 2016). Thus, there is not
a single time point at which individuals should be targeted for in-
volvement in PS, and instead, they should be given as many options as
possible of when and how to access the service (McCarthy & Mastin,
2016; Wood, 2014). This may mean having the opportunity to self‐refer
or to have more control during the selection process of their peer
supporter. Moreover, concerns such as travel arrangements, lack of
available time, or fear of initial meetings could also be alleviated with a
flexible format, such as options to speak over the phone, internet, or in‐
person and for the PS recipient to influence/choose the date/time of
the session (Wood, 2014). Liaghat (2017) found in‐person sessions,
particularly effective, while Nicholas et al. (2009) stated that online
delivery showed promise; having greater selection gives recipients more
options to choose from.
Motivations for patients
Of the reasons for people choosing to get involved in PS, informa-
tional, emotional and decision‐making support, all were identified as
significant. An opportunity to learn more about their condition and
have support in making decisions surrounding their care has also
been found as common motivators in studies assessing PS in cancer
(Lu, You, Man, Loh, & Young, 2014) and cardiovascular disease
(Wright et al., 2001). To ensure individuals are aware that PS is an
opportunity to gain access to information and help with decision‐
making, accurate promotion of PS by clinicians is crucial (Wood,
2014). Additionally, framing PS in a way that identifies peer
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supporters as role models may help in normalising how patients feel
and give them an incentive to get involved (Hughes et al., 2009).
Implications for clinical practice and research
National policy recommends that every person in the United King-
dom with CKD have access to PS; however, this narrative review
highlights that there are a number of barriers, which impede the
uptake of PS. As there are few studies that assess PS in kidney care,
there is plenty more to be learned at a national and international
level about what both patients and clinicians have experienced with
PS to enable more people to benefit.
Existing evidence suggests numerous strategies units can em-
ploy if they struggle with overcoming staff‐ or patient‐related
barriers. First, clinicians need the training to understand the likely
benefit of PS and the logistics of the local PS service, so that they
feel confident and motivated to discuss the service with and refer
potential recipients. Research evidencing the most effective meth-
ods of increasing clinician awareness would be valuable. Second, PS
services need to be designed to be as inclusive as possible to allow
recipients to assess PS at the time and in a way that suits them
personally. This means offering PS in a variety of formats and at all
stages of kidney disease, and so on. It is recommended to have
individuals passionate about PS take the lead with its organisation,
and to consult patients and carers, so the service is tailored to the
needs of people with kidney disease (Wood, 2014). Furthermore, it
will be essential to have investment from senior level management
and a consistent set of volunteers to help sustain the programme.
As only two articles in the narrative review assessed both
patient and healthcare professional perspectives simultaneously,
there is a need for further studies to evaluate both. Moreover,
many of the articles focused solely on one unit within the UK, so
more studies need to be carried out on a national and international
level to ensure the results are more generalisable to the greater
population. While there have been studies within this context
in other countries such as the United States (Liaghat, 2017) and
Canada (Nicholas et al., 2009), more work within this field
could increase the overall awareness and prioritisation of PS in
kidney care.
Limitations
Given the nature of a narrative review, several limitations must be
mentioned when assessing its value. First, due to the small number of
articles included, the findings should not be considered an entire
comprehensive overview of all barriers and facilitators to PS in
kidney care. Although a rigorous and specific search strategy was
employed, there may also have been some subjectivity in the actual
selection of which articles were included, as well as during the the-
matic analysis. Moreover, given many of the articles' qualitative
methodology, the results cannot be considered generalisable to the
UK population. Despite such limitations, the findings still present a
thorough overview and understanding of the topic and offer valuable
suggestions for future practice and research.
CONCLUSION
This narrative review has highlighted the most prominent staff‐ and
patient‐related barriers and facilitators for the uptake of PS among
people with CKD in the United Kingdom within the current litera-
ture. Among the staff barriers, low referrals and difficulty matching
peer supporters deterred PS from being successful, with specific
reasons behind each barrier identified. For staff‐related facilitators,
promoting PS with clinicians aided its overall success. The main
patient barriers cited were concerns regarding the peer supporter
relationship dynamic and the actual format and delivery of the
service. Having an inclusive service, which provided the recipient
with greater autonomy in decision‐making, was the primary facil-
itator among patients. Recommendations for clinical practice in-
clude promoting PS with clinicians to increase their motivation to
refer and empowering people to access PS, which suits their specific
needs. As a number of studies did not review patient and provider
perspectives collectively, further study is required to gain a more
holistic understanding of the barriers and facilitators to the uptake
of PS. Future studies should include kidney units throughout the
United Kingdom and internationally that already have PS estab-
lished to understand what has helped or impeded its success, as
well as units that have yet to implement a PS service to learn what
would be required for initiation.
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